Mineralys Therapeutics, Inc. (MLYS) PT Raised to $51 at BofA Securities
Tweet Send to a Friend
BofA Securities analyst Tim Anderson raised the price target on Mineralys Therapeutics, Inc. (NASDAQ: MLYS) to $51.00 (from $46.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
